DeepTek’s AI Joins Hands With Mongolia's Fight Against TB
As per the studies by WHO, Mongolia is one of the countries with the highest TB prevalence, with around 4000 TB cases reported yearly. In 2020, the tuberculosis death rate in Mongolia was 9.8 cases per 100,000 people.
The Ministry of Health Mongolia's National Center for Communicable Diseases (NCCD) has joined hands with DeepTek to improve its screening capabilities and make the process faster and affordable. The NCCD is responsible for infectious disease control in Mongolia and plays a crucial role in preventing and controlling the spread of contagious diseases.
DeepTek's AI-powered TB screening solution Genki analyses Chest X Rays within a minute to automatically triage TB suspects. Only the suspects triaged positive on DeepTek's AI solution are sent for further confirmatory molecular tests.
“This substantially reduces the need for conducting expensive molecular tests – bringing down the overall costs. Instant results also ensure that suspected patients can be educated on the spot and cases are not lost for follow-up,” the company said in a statement.
"Mongolia is one of the 30 countries in the world with a high burden of tuberculosis (TB). The prevalence of the disease is 757 per 100,000 population. And the incidence rate is 428 per 100,000 population. However, the current case detection rate is only 30 per cent. Thus, the introduction of this artificial intelligence system will strengthen the capacity of radiologists and TB doctors to detect TB. It will also be possible to effectively organise active case finding in remote villages and regions,” said Tsolmon Boldoo, Epidemiologist, TB Surveillance & Research Department NCCD, Mongolia.
“At DeepTek, we are developing cutting edge technology solutions to make radiology more accurate, affordable and accessible. By bringing community TB screening and AI together, we can improve the health of our community and save lives; while enabling substantial cost savings. We will continue to innovate to win the fight against TB," said Ajit Patil, Co-Founder, DeepTek.
